Chronic Paronychia

http://www.fpnotebook.com/DER/Nails/ChrncPrnych.htm

http://www.fpnotebook.com/
Chronic Paronychia
I. See Also A. Acute Paronychia B. Hand Infection II. Definition A. More than 6 weeks of nail fold inflammation III. Pathophysiology A. Cuticle separates from nail plate resulting in a space between nail fold and nail plate B. Resulting pocket accumulates irritants, as well as fungi and bacteria IV. Mechanisms A. Exposures 1. Exposure to water with irritants or Alcohol 2. Repeated exposure to moist environment B. Occupation 1. Baker 2. Bartender 3. Dishwasher 4. Housekeeper 5. Homemaker 6. Swimmer C. Comorbid condition 1. Diabetes Mellitus 2. Immunocompromised condition 3. Medications a. Retinoids b. Indinavir (Antiretroviral agent) c. Cetuximab V. Etiology A. Candida albicans (95%) 1. May only be colonizer and not related to chronic Paronychia pathogenesis B. Atypical Mycobacteria C. Gram Negative Rods D. Gram Negative Cocci VI. Differential Diagnosis A. Metastatic cancer B. Subungual Melanoma C. Squamous Cell Carcinoma VII. Signs and Symptoms A. Early characteristics 1. Swollen and tender nail folds 2. Less redness than in Acute Paronychia B. Later characteristics

1 of 3

09/02/2013 17:59

Chronic Paronychia

http://www.fpnotebook.com/DER/Nails/ChrncPrnych.htm

1. Nail plates thick and discolored 2. Nail plate with transverse ridges C. Duration: 6 weeks or longer VIII. Management A. Avoid precipitating factors 1. Avoid irritants (use hypoallergenic products, dye and perfume free) 2. Avoid prolonged water exposure 3. Avoid nail trauma a. Avoid manicures b. Avoid finger sucking c. Keep nails short 4. Use gloves to prevent frequent emersion of finger tips a. Avoid vinyl gloves (or use cotton gloves underneath) 5. Apply Skin Lubricants after hand washing B. First Line management: Topical Corticosteroids with or without Topical Antifungals 1. Topical Corticosteroids (preferred) a. Medium to high potency agents for up to 3 weeks b. Systemic Corticosteroids could be considered in severe, diffuse cases c. Tosti (2002) J Am Acad Dermatol 47:73 2. Topical Antifungal Medications (for up to 1 month) a. Nystatin cream or b. Clotrimazole cream or c. Terbinafine (Lamisil) in refractory cases 3. Consider combination agent a. Nystatin with Triamcinolone b. Clotrimazole with Betamethasone (Lotrisone) i. One of few cases where this potent combination is appropriate c. However, Corticosteroids appear to be effective alone C. Second Line management: Treat as Acute Paronychia 1. See Acute Paronychia management for antibiotics and other measures (e.g. soaks) D. Third Line medications: Systemic Antifungals 1. Fluconazole 100 mg orally once daily for 7-14 days or 2. Itraconazole 200 mg orally twice daily for 7 days E. Refractory cases: Surgery 1. Proximal nail fold and nail plate excision or 2. Marsupialization of Eponychium F. Special circumstances 1. Indinavir (Antiretroviral agent) a. Consider switching to other Antiretroviral b. Garcia-Silva (2002) Drug Saf 25:993 2. Cetuximab (epidermal growth factor agent) a. Associated Paronychia is treated with Doxycycline b. Shu (2006) Br J Dermatol 154:191 IX. References A. Brook (1990) Ann Emerg Med 19:994 B. Hochman (1995) Int J Dermatol 34:385 C. Rigopoulos (2008) Am Fam Physician 77:339 D. Rockwell (2001) Am Fam Physician 63(6):113 E. Jebson (1998) Hand Clin 14:547

2 of 3

09/02/2013 17:59

Chronic Paronychia

http://www.fpnotebook.com/DER/Nails/ChrncPrnych.htm

Chronic paronychia (C0581341)

Concepts English Spanish Parent Concepts Sources Disease or Syndrome (T047) Chronic paronychia paroniquia cronica Paronychia Inflammation (C0030578), Chronic infectious disease (C0151317), Chronic disease of skin (C1290009), Chronic dermatitis (C0262975) SCTSPA, SNOMEDCT Derived from the NIH UMLS (Unified Medical Language System)

Please see the Terms and Conditions. Please also see the privacy statement regarding advertising on this page. Although access to this page is not restricted, the information found here is intended for use by medical providers. Patients should address specific medical concerns with their physicians. This page was written by Scott Moses, MD. This page was last revised on 5/29/2009 10:37:06 AM. This page was last published on 3/22/2010. Please send comments and questions to the editor. Contact information may be found on the page About the Family Practice Notebook. These pages are best viewed with Microsoft Internet Explorer 6.0. 2008, Family Practice Notebook, LLC

3 of 3

09/02/2013 17:59